Dr. Teuta Zoto Mustafayev
Dr. Teuta Zoto Mustafayev — radiation oncologist of the radiation oncology department at Acıbadem Maslak Hastanesi in Istanbul. She specializes in one of the most technologically advanced areas of modern radiation oncology: MR-guided adaptive stereotactic body radiotherapy (MR-guided adaptive SBRT) and stereotactic radiosurgery (SRS).
Received her medical education within the MD-PhD program in pharmacology of Hacettepe University in Ankara. Completed residency in radiation oncology at the Department of Radiation Oncology of the same university and finished it in 2017. Since 2017 she has been working at Acıbadem Maslak Hastanesi.
In 2026 she was admitted to the Fellowship program in radiation oncology at the University of Toronto, Canada.
In clinical practice she uses the MRIdian Linac system (manufactured by ViewRay) — a linear accelerator with integrated MRI, as well as TrueBeam, Rapid Arc units and equipment for intraoperative radiation therapy. She treats tumors of the lungs, prostate, adrenal glands, spine, brain metastases, cervical cancer and head and neck tumors.
She is the first author of a 2024 publication in the BMC Cancer journal on the clinical and radiological effects of bevacizumab for radionecrosis after stereotactic brain radiotherapy — a multicenter study involving 10 centers. Co-author of works on MR-guided radiotherapy in the journals Cureus (2019), British Journal of Radiology (2021) and Strahlentherapie und Onkologie (2024). Co-author of multicenter studies of the Turkish Society for Radiation Oncology (TROD) on nasopharyngeal cancer.
Collaborates with the team of professors Enis Ozyar and Banu Atalar of Acibadem University, as well as with the Rutgers Cancer Institute of New Jersey, USA.
Is a member of the Turkish Society for Radiation Oncology (TROD).
Accepts patients in Turkish and English.
Achievements and awards
About Dr. Teuta Zoto Mustafayev
- MR-guided online adaptive stereotactic body radiotherapy (MR-guided online adaptive SBRT)
- Stereotactic radiosurgery (SRS) of brain metastases
- Stereotactic body radiotherapy (SBRT) of tumors of the lungs, prostate, adrenal glands and spine
- MR-guided radiotherapy (MRgRT) of cervical cancer as an alternative to brachytherapy
- Management of radionecrosis after stereotactic brain radiotherapy
- Radiation therapy of head and neck tumors (nasopharyngeal cancer)
- Faculty of Medicine, MD-PhD program in pharmacology, Hacettepe University, Ankara, Turkey
- 2010–2011 — residency in radiation oncology, Department of Radiation Oncology, Hacettepe University, Ankara
- 2017 — completion of residency in radiation oncology, Hacettepe University, Ankara
- 2026 — Fellowship program in radiation oncology, University of Toronto, Canada
- Acıbadem Maslak Hastanesi, Istanbul, Turkey — radiation oncologist of the radiation oncology department, from 2017 to the present.
- Acibadem University School of Medicine, Istanbul — Department of Radiation Oncology, academic work.
- Hacettepe University, Ankara, Turkey — Department of Radiation Oncology, residency training (2010–2017).
- University of Toronto, Canada — Fellowship program in radiation oncology, since 2026.
- In clinical practice she uses the MRIdian Linac system (ViewRay) — a linear accelerator with integrated MRI system, as well as TrueBeam, Rapid Arc units and intraoperative radiation therapy.
Dr. Teuta Zoto Mustafayev conducts active scientific and research work in the field of radiation oncology, and is the author and co-author of more than 30 publications in international peer-reviewed editions.
Main topics: MR-guided adaptive stereotactic body radiotherapy (MRgSBRT), stereotactic radiosurgery (SRS), radiation oncology of tumors of the lungs, prostate, brain and cervix, management of radionecrosis after radiation therapy.
Key publications:
- “Clinical and radiological effects of bevacizumab for radionecrosis after stereotactic brain radiotherapy” — first author, BMC Cancer journal, 2024
- “MR-guided stereotactic body radiotherapy of primary lung tumors” — co-author, Strahlentherapie und Onkologie journal, 2024
- “MR-guided adaptive SBRT for prostate cancer” — co-author, British Journal of Radiology, 2021
- “MR-guided radiotherapy of cervical cancer as an alternative to brachytherapy” — co-author, Advances in Radiation Oncology journal, 2020
- “First 500 fractions delivered on the MR-guided radiotherapy system” — co-author, Cureus journal, 2019
- “In Regard to Kim et al” — co-author, International Journal of Radiation Oncology, Biology, Physics, 2017
- Co-author of multicenter studies of the Turkish Society for Radiation Oncology (TROD), including TROD 01-001 on nasopharyngeal cancer.
Co-author collaborations: Rutgers Cancer Institute of New Jersey, USA; team of professors Enis Ozyar and Banu Atalar, Acibadem University.
- Turkish Society for Radiation Oncology (TROD)
- European Society for Radiotherapy and Oncology (ESTRO)
- American Society for Radiation Oncology (ASTRO)
Acıbadem Maslak Hastanesi is one of the largest clinics of the Acıbadem Healthcare Group, with international JCI (Joint Commission International) accreditation.
The oncology profile is one of the central directions of the clinic: work is conducted in a multidisciplinary format with the participation of specialists in medical oncology, radiation oncology, surgical oncology, neurology, molecular oncology and pathology.
The key advantage in radiation oncology is the availability of the MRIdian Linac system (manufactured by ViewRay), which combines MRI and a linear accelerator in real time; Acıbadem Maslak Hastanesi is among the first medical centers in the world and became the first in Turkey to install this system. In addition to the MRIdian Linac, the clinic uses TrueBeam, Rapid Arc units, the Da Vinci surgical robot, a whole-body MRI scanner and equipment for intraoperative radiation therapy.
